World

China has released a set of coins for the Year of the Horse 2026, including a 10 kg gold coin

Jan 01, 2026

Beijing [China], January 1: The Chinese commemorative coin set for the Year of the Horse 2026 has caused a sensation among collectors with its limited edition of 18 gold coins.
The People's Bank of China (PBOC) recently released a commemorative coin set for the Year of the Horse 2026. The coins were released to the market in late November 2026 and will be distributed by the China National Gold Corporation, according to the Chinese government's official website.
The collection includes 6 gold coins, 4 silver coins, and 1 platinum coin. The most valuable coin is a round gold coin weighing 10 kg, with a diameter of 180 mm and a face value of 100,000 yuan (approximately 370 million VND). This is a limited edition, with only 18 pieces ever issued.
The most widely issued type is a round silver coin weighing 15g, with a diameter of 33mm, and valued at 5 yuan. The PBOC stated that a maximum of 250,000 pieces will be released to the market.
According to the PBOC, these coins have both collectible value and are legal tender, allowing them to circulate in China.
Previously, The Straits Times reported that the Monetary Authority of Singapore (MAS) also introduced a commemorative coin set for the Year of the Horse 2026, featuring a horse design against the backdrop of Punggol Water Park.
China's commemorative coin set has attracted the attention of collectors and those who appreciate traditional values. Its issuance is also seen as a way to honor folk culture and affirm the role of physical currency in economic and cultural life.
The PBOC stated that it will ensure the planned issuance quantity, making it possible for the public and collectors to own these coins with special significance.
Source: Thanh Nien Newspaper

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026